Brainstorm Cell Shares Outstanding vs. Debt To Equity
| GHDN Stock | EUR 2.69 0.00 0.00% |
For Brainstorm Cell profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Brainstorm Cell to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Brainstorm Cell Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Brainstorm Cell's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Brainstorm Cell Therapeutics over time as well as its relative position and ranking within its peers.
Brainstorm |
Brainstorm Cell Ther Debt To Equity vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Brainstorm Cell's current stock value. Our valuation model uses many indicators to compare Brainstorm Cell value to that of its competitors to determine the firm's financial worth. Brainstorm Cell Therapeutics is one of the top stocks in shares outstanding category among its peers. It also is one of the top stocks in debt to equity category among its peers . The ratio of Shares Outstanding to Debt To Equity for Brainstorm Cell Therapeutics is about 39,124 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brainstorm Cell's earnings, one of the primary drivers of an investment's value.Brainstorm Debt To Equity vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Brainstorm Cell |
| = | 36.54 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Brainstorm Cell |
| = | 934.00 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Brainstorm Debt To Equity Comparison
Brainstorm Cell is currently under evaluation in debt to equity category among its peers.
Brainstorm Cell Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Brainstorm Cell, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Brainstorm Cell will eventually generate negative long term returns. The profitability progress is the general direction of Brainstorm Cell's change in net profit over the period of time. It can combine multiple indicators of Brainstorm Cell, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of central nervous system adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was founded in 2000 and is headquartered in New York, New York. BRAINSTORM operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 31 people.
Brainstorm Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Brainstorm Cell. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Brainstorm Cell position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Brainstorm Cell's important profitability drivers and their relationship over time.
Use Brainstorm Cell in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brainstorm Cell position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainstorm Cell will appreciate offsetting losses from the drop in the long position's value.Brainstorm Cell Pair Trading
Brainstorm Cell Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Brainstorm Cell could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brainstorm Cell when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brainstorm Cell - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brainstorm Cell Therapeutics to buy it.
The correlation of Brainstorm Cell is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brainstorm Cell moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brainstorm Cell Ther moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brainstorm Cell can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Brainstorm Cell position
In addition to having Brainstorm Cell in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in Brainstorm Stock
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
To fully project Brainstorm Cell's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Brainstorm Cell Ther at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Brainstorm Cell's income statement, its balance sheet, and the statement of cash flows.